The Role of Imaging in Vogt-Koyanagi-Harada Syndrome Management
Medical imaging has become an essential component in the diagnosis and management of Vogt-Koyanagi-Harada syndrome. Because VKH primarily affects deep eye structures, advanced imaging tools allow clinicians to visualize inflammation that may not be apparent during routine examination.
Optical coherence tomography (OCT) is widely used to assess retinal thickness and detect fluid accumulation beneath the retina. These findings are characteristic of VKH during the acute phase and help differentiate it from other causes of uveitis. OCT also allows clinicians to monitor response to therapy and identify early signs of relapse.
Fluorescein and indocyanine green angiography provide additional insight into vascular changes within the retina and choroid. These techniques reveal patterns of inflammation and leakage that support diagnosis and guide treatment decisions.
Imaging is not limited to the eyes. In cases with neurological involvement, brain imaging may be used to evaluate meningeal inflammation. This comprehensive approach ensures that systemic manifestations are not overlooked.
Regular imaging follow-up plays a preventive role by detecting subclinical disease activity. Adjustments to therapy can be made before symptoms worsen, reducing the risk of permanent damage.
As imaging technology continues to evolve, its role in VKH management will expand further, supporting earlier diagnosis, precise monitoring, and improved patient outcomes.